Celltrion Healthcare decides to launch Remsima with Pfizer on November
Celltrion Healthcare announced it confirmed the release of Remsima(U.S. product name: Inflectra) with the U.S. exclusive distribution partnering company Pfizer in the world’s largest biomedicine market, the U.S., on November.
Celltrion Healthcare continuously made discussions about the sales str...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
